Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, announced today that a new Category I Current Procedural Terminology (CPT) code has been published by the American Medical Association (AMA) for the AspirinWorks® Test Kit. This important action becomes effective January 1, 2010.
"We are very pleased that the AMA has created this unique CPT code that describes our AspirinWorks product," said Douglass Simpson, Corgenix President and Chief Executive Officer. "These codes are important to patients, physicians and hospitals because they recognize the widespread acceptance of the test and the clinical evidence supporting testing for levels of thromboxane metabolites in urine."
Category I CPT codes are restricted to clinically recognized and generally accepted services, and not emerging technologies, services or procedures.
The new CPT code for AspirinWorks is:
- 84431 Thromboxane metabolite(s), including thromboxane if performed, urine
CPT codes are the most widely accepted form of medical nomenclature used to report medical procedures and services. The purpose of CPT is to provide a uniform language that accurately describes medical, surgical and diagnostic services. Physicians, hospitals and other health care providers use CPT codes to report medical services to private and public health insurance systems for purposes of reimbursement. A standard system of coding also allows for reliable nationwide data collection. CPT is trademarked by the AMA, which first published the codes in 1966.
Among the AMA's stated criteria for a new Category I CPT code are requirements that: